Sleep Analysis Module
Neurotronics, LLC · Decision date Oct 9, 2026
What did the FDA decide?
FDA recorded a substantial equivalence decision (SESE) for K261521, the Sleep Analysis Module submitted by Neurotronics, LLC of Alachua, Florida. The decision date is 2026-10-09 and the application was received 05/07/2026, per the agency's 510(k) listing. The record carries product code OLZ and specialty Neurology, and one FDA page associates the submission with automatic event detection software for polysomnography with electroencephalograph.
Under 510(k) review, SESE denotes clearance of the submitted device as substantially equivalent to a predicate, not premarket approval of a new system. The record does not identify the predicate device, the specific software functions or components assessed, or any performance data, so the technical basis for the equivalence finding remains unknown. No summary statement is included in the supplied data, and no clinical or labeling conclusions should be drawn from the decision alone.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Oct 9, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261521
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Neurotronics, LLC
- Product code
- OLZ
- Decision code
- SESE
- Decision date
- Oct 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automatic Event Detection Software For Polysomnograph With Electroencephalograph.
- Applicant
- Neurotronics, LLC
- Product code
- OLZ
- FDA device class
- 2
FDA decision timeline
K261521 received
Application receipt date recorded by FDA.
K261521 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Neurotronics, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Alachua, FL
Sources and methodology
- Original FDA record: K261521
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records